| ■ FDA Data Notes Possible Link Between Suicidal Behavior and Epilepsy Drugs: Report | 2008.06.06 |
| A group of 11 popular epilepsy drugs may be linked to suicidal behavior among users, according to an unpublished analysis from the U.S. Food and Drug Administration cited by a Wall Street Journal reporter in the newspaper's online "Health Blog." Clinical data that may spur the FDA to add warnings to the medicines' labels were summarized last week to scientists meeting in Phoenix and New York City, reporter Alicia Mundy wrote in Wednesday's blog entry. Attendees at the New York City meeting told Mundy that the FDA appeared ready to lump the drugs together as a "class," she wrote. Mundy's entry mentioned the Pfizer drugs Lyrica and Neurontin (now generically called gabapentin), Johnson & Johnson's Topamax, Abbott Labs' Depakote, and UBC's Keppra. |